Femasys FEMY
NASDAQ FEMY
$2.96 +0.23 (+8.42%)
At close: Aug 21, 2026 · 4:00 PM EDT

Femasys (FEMY) Net Equity Issued and Repurchased (2020 - 2025)

Femasys' (FEMY) quarterly Net Equity Issued and Repurchased came in at $3.5 million in Q4 2025, up 495.55% on a QoQ basis from -$882026.0 in Q2 2025.

Femasys (FEMY) Net Equity Issued and Repurchased (2020 - 2025) Analysis & Trends

Femasys (FEMY) has 6 years of Net Equity Issued and Repurchased data on file, last reported at $3.5 million in Q4 2025.

  • Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $3.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $8.0 million (up 1.28% YoY) and the FY2025 annual result came in at $8.0 million, changed N/A from the prior year.
  • Net Equity Issued and Repurchased rose to $3.5 million in Q4 2025, from -$882026.0 in the prior quarter.
  • In the past five years, Net Equity Issued and Repurchased ranged from a high of $31.7 million in Q2 2021 to a low of -$882026.0 in Q2 2025.
  • A 5-year average of $5.0 million and a median of $59583.0 in 2022 frame the typical range for Net Equity Issued and Repurchased.
  • Annual changes were most pronounced in 2021 — Net Equity Issued and Repurchased plunged 85.25% — and 2024, when it surged 257830.63%.
  • Tracing FEMY's Net Equity Issued and Repurchased over 5 years: stood at $14401.0 in 2021, then soared by 313.74% to $59583.0 in 2022, then jumped by 12758.86% to $7.7 million in 2023, then sank by 110.47% to -$802242.0 in 2024, then jumped by 534.88% to $3.5 million in 2025.
  • The last three Net Equity Issued and Repurchased figures came in at $3.5 million (Q4 2025), -$882026.0 (Q2 2025), and $5.4 million (Q1 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Intuitive Surgical 134.13 Bn 128.91 Bn 1.96 Bn -
2 Becton Dickinson 52.76 Bn 51.90 Bn 2.32 Bn -
3 Alcon 35.81 Bn 34.46 Bn 1.68 Bn -
4 Resmed 33.72 Bn 32.25 Bn 861.22 Mn 29.31 Mn
5 Medline 29.38 Bn 26.70 Bn 2.22 Bn -
6 West Pharmaceutical Services 25.00 Bn 24.57 Bn 329.20 Mn -
7 Solventum 15.46 Bn 15.06 Bn 1.29 Bn -
8 Cooper Companies 14.88 Bn 14.74 Bn 735.40 Mn -
9 Baxter International 13.58 Bn 11.43 Bn 1.03 Bn -
10 Femasys 9.97 Mn 8.53 Mn 189,391.00 -

Historic Data

Download Data
DateValue
Dec 31, 2025 3.49 Mn
Dec 31, 2025 3.49 Mn
Jun 30, 2025 -882,026.00
Jun 30, 2025 -882,026.00
Mar 31, 2025 5.39 Mn
Mar 31, 2025 5.39 Mn
Jun 30, 2024 -802,242.00
Jun 30, 2024 -802,242.00
Mar 31, 2024 8.70 Mn
Mar 31, 2024 8.70 Mn
Dec 31, 2023 7.66 Mn
Dec 31, 2023 7.66 Mn
Mar 31, 2023 3,373.00
Mar 31, 2023 3,373.00
Dec 31, 2022 59,583.00
Dec 31, 2022 59,583.00
Dec 31, 2021 14,401.00
Dec 31, 2021 14,401.00
Jun 30, 2021 31.72 Mn
Jun 30, 2021 31.72 Mn